"Gemfibrozil" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A lipid-regulating agent that lowers elevated serum lipids primarily by decreasing serum triglycerides with a variable reduction in total cholesterol.
Descriptor ID |
D015248
|
MeSH Number(s) |
D02.241.081.114.968.500.750 D02.241.081.944.509.350 D02.355.726.305.750 D02.455.426.559.389.657.654.305.750 D10.251.400.895.593.350
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Gemfibrozil".
Below are MeSH descriptors whose meaning is more specific than "Gemfibrozil".
This graph shows the total number of publications written about "Gemfibrozil" by people in this website by year, and whether "Gemfibrozil" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2009 | 1 | 0 | 1 |
2010 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Gemfibrozil" by people in Profiles.
-
Wang G, Liu X, Guo Q, Namura S. Chronic treatment with fibrates elevates superoxide dismutase in adult mouse brain microvessels. Brain Res. 2010 Nov 04; 1359:247-55.
-
Guo Q, Wang G, Liu X, Namura S. Effects of gemfibrozil on outcome after permanent middle cerebral artery occlusion in mice. Brain Res. 2009 Jul 07; 1279:121-30.